Business Description
Integragen
NAICS : 325412
SIC : 2834
ISIN : FR0010908723
Compare
Compare
Traded in other countries / regions
ALINT.France7N8.Germany IPO Date
2010-06-18Description
Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.19 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | 12.07 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.96 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.3 | |||||
| 3-Year EBITDA Growth Rate | 46.1 | |||||
| 3-Year EPS without NRI Growth Rate | 41.5 | |||||
| 3-Year Book Growth Rate | -2.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.84 | |||||
| 9-Day RSI | 62.71 | |||||
| 14-Day RSI | 59.14 | |||||
| 6-1 Month Momentum % | -17.09 | |||||
| 12-1 Month Momentum % | -49.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.54 | |||||
| Quick Ratio | 1.46 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 20.65 | |||||
| Days Sales Outstanding | 108.73 | |||||
| Days Payable | 86.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 15.09 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.45 | |||||
| Operating Margin % | -1 | |||||
| Net Margin % | -0.23 | |||||
| ROE % | -1.29 | |||||
| ROA % | -0.3 | |||||
| ROIC % | -1.58 | |||||
| ROC (Joel Greenblatt) % | -34.25 | |||||
| ROCE % | -1.95 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 265 | |||||
| PS Ratio | 0.32 | |||||
| PB Ratio | 1.85 | |||||
| Price-to-Tangible-Book | 1.83 | |||||
| EV-to-EBIT | -45.76 | |||||
| EV-to-EBITDA | 34.32 | |||||
| EV-to-Revenue | 0.22 | |||||
| Price-to-Projected-FCF | 2.21 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Graham-Number | 4.82 | |||||
| Price-to-Net-Current-Asset-Value | 2.12 | |||||
| Earnings Yield (Greenblatt) % | -2.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Integragen Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 11.019 | ||
| EPS (TTM) (€) | -0.003 | ||
| Beta | 0.7 | ||
| Volatility % | 40.95 | ||
| 14-Day RSI | 59.14 | ||
| 14-Day ATR (€) | 0.022159 | ||
| 20-Day SMA (€) | 0.51315 | ||
| 12-1 Month Momentum % | -49.33 | ||
| 52-Week Range (€) | 0.434 - 0.93 | ||
| Shares Outstanding (Mil) | 6.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Integragen Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Integragen Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Integragen Frequently Asked Questions
What is Integragen(XPAR:ALINT)'s stock price today?
The current price of XPAR:ALINT is €0.53. The 52 week high of XPAR:ALINT is €0.93 and 52 week low is €0.43.
When is next earnings date of Integragen(XPAR:ALINT)?
The next earnings date of Integragen(XPAR:ALINT) is .
Does Integragen(XPAR:ALINT) pay dividends? If so, how much?
Integragen(XPAR:ALINT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers